Phibro Animal Health Corporation Revenue 2020–2025
Phibro Animal Health Corporation annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Phibro Animal Health Corporation revenue for the quarter ending March 31, 2026 was 383.5 M, a 10.27% increase year-over-year.
- Phibro Animal Health Corporation revenue for the twelve months ending March 31, 2026 was 1.5 B.
- Phibro Animal Health Corporation annual revenue for 2025 was 1.3 B, a 27.37% increase from 2024.
- Phibro Animal Health Corporation annual revenue for 2024 was 1.0 B, a 4.07% increase from 2023.
- Phibro Animal Health Corporation annual revenue for 2023 was 977.9 M, a 3.78% increase from 2022.
- Phibro Animal Health Corporation annual revenue for 2022 was 942.3 M.
Phibro Animal Health Corporation (PAHC) — Frequently Asked Questions
Phibro Animal Health Corporation (PAHC) is a publicly traded US company. It has a market capitalization of $1.25B. In fiscal 2025 it reported revenue of $1.30B and net income of $48M. Explore PAHC's stock price, financial statements, earnings history, margins and key ratios below.
What is Phibro Animal Health Corporation's market cap?
Phibro Animal Health Corporation (PAHC) has a market capitalization of $1.25B.
What is the PAHC stock price?
PAHC trades at $30.98 (-0.63% on the day).
How much revenue does Phibro Animal Health Corporation make?
Phibro Animal Health Corporation reported revenue of $1.30B in fiscal 2025.
Is PAHC profitable?
In fiscal 2025, Phibro Animal Health Corporation reported net income of $48M.
What is PAHC's P/E ratio?
Based on diluted EPS, PAHC has a price-to-earnings (P/E) ratio of about 26.0.